| Indicators | Browse All

HeartSciences Inc. (HSCS)

Healthcare | Medical Devices | Southlake, United States | NasdaqCM
2.64 USD -0.10 (-3.650%) ⇩ (July 13, 2026, 4 p.m. EDT)

Short-term:★★☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:41 a.m. EDT

The immediate outlook is clouded by a chaotic corporate restructuring where a crypto mining entity is merging with a medical device firm, creating severe valuation ambiguity. While the stock recently rallied off a low, the underlying business is in freefall, having lost over 97% of its value over the last three years due to collapsing revenues and massive losses. The balance sheet is fragile, with debt significantly outweighing equity and negative operating cash flow, making survival uncertain without the merger's success. There is no income to rely on, and the statistical models offer no guidance given the extreme volatility and lack of historical data post-restructuring. This is a speculative gamble on a turnaround rather than an investment in a viable company.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.110536
MSTL0.112644
MSTL_680.130807
MSTL_68_930.155878
MSTL_930.169713
AutoTheta0.208157
AutoARIMA0.215695

Forecast horizon: 60 days | Selected: AutoETS

Forecast Reliability
Score 17%
H-stat 62.35
Ljung-Box p 0.000
Jarque-Bera p 0.001
Excess Kurtosis -0.07
Attribute Value
Sector Healthcare
Debt to Equity Ratio 145.813
Revenue per Share 0.004
Market Cap 8,686,524
Forward P/E -0.93
Beta 1.79
Previous Name Heart Test Laboratories, Inc.
Website https://heartsciences.com

Info Dump

Attribute Value
52 Week Change -0.37011492
Address1 550 Reserve Street
Address2 Suite 360
All Time High 600.0
All Time Low 1.63
Ask 3.37
Ask Size 2
Average Analyst Rating 1.5 - Strong Buy
Average Daily Volume10 Day 137,790
Average Daily Volume3 Month 2,335,824
Average Volume 2,335,824
Average Volume10Days 137,790
Beta 1.792
Bid 1.97
Bid Size 2
Book Value 0.833
City Southlake
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.64
Current Ratio 1.194
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 2.75
Day Low 2.6
Debt To Equity 145.813
Display Name HeartSciences
Ebitda -7,768,315
Ebitda Margins 0.0
Enterprise To Ebitda -1.143
Enterprise To Revenue 1,024.181
Enterprise Value 8,878,621
Eps Current Year -3.375
Eps Forward -2.825
Eps Trailing Twelve Months -4.31
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.13098
Fifty Day Average Change 0.5090201
Fifty Day Average Change Percent 0.23886667
Fifty Two Week Change Percent -37.011494
Fifty Two Week High 4.39
Fifty Two Week High Change -1.7499998
Fifty Two Week High Change Percent -0.3986332
Fifty Two Week Low 1.63
Fifty Two Week Low Change 1.0100001
Fifty Two Week Low Change Percent 0.61963195
Fifty Two Week Range 1.63 - 4.39
Financial Currency USD
First Trade Date Milliseconds 1,655,386,200,000
Float Shares 2,420,372
Forward Eps -2.825
Forward P E -0.9345133
Free Cashflow -4,213,324
Full Exchange Name NasdaqCM
Full Time Employees 15
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.57919
Gross Profits 5,021
Has Pre Post Market Data 1
Held Percent Insiders 0.23244
Held Percent Institutions 0.06554
Implied Shares Outstanding 3,290,350
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ipo Expected Date 2,022-06-15
Language en-US
Last Fiscal Year End 1,745,971,200
Last Split Date 1,715,904,000
Last Split Factor 1:100
Long Business Summary HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Long Name HeartSciences Inc.
Market us_market
Market Cap 8,686,524
Market State PRE
Max Age 86,400
Message Board Id finmb_51732680
Most Recent Quarter 1,769,817,600
Name Change Date 2,026-07-13
Net Income To Common -8,485,301
Next Fiscal Year End 1,777,507,200
Non Diluted Market Cap 9,015,559
Number Of Analyst Opinions 2
Open 2.74
Operating Cashflow -7,340,799
Operating Margins -899.3956
Payout Ratio 0.0
Phone 682 237 7781
Pre Market Change -0.09000015
Pre Market Change Percent -3.4090965
Pre Market Price 2.55
Pre Market Time 1,784,019,669
Prev Name Heart Test Laboratories, Inc.
Previous Close 2.74
Price Eps Current Year -0.7822223
Price Hint 4
Price To Book 3.169268
Price To Sales Trailing12 Months 1,002.0215
Profit Margins 0.0
Quick Ratio 0.796
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.5
Region US
Regular Market Change -0.0999999
Regular Market Change Percent -3.64963
Regular Market Day High 2.75
Regular Market Day Low 2.6
Regular Market Day Range 2.6 - 2.75
Regular Market Open 2.74
Regular Market Previous Close 2.74
Regular Market Price 2.64
Regular Market Time 1,783,972,801
Regular Market Volume 32,398
Return On Assets -0.73509
Return On Equity -3.82323
Revenue Per Share 0.004
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 3,290,350
Shares Percent Shares Out 0.0376
Shares Short 123,640
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 43,409
Short Name HeartSciences Inc.
Short Percent Of Float 0.038399998
Short Ratio 0.02
Source Interval 15
State TX
Symbol HSCS
Target High Price 12.0
Target Low Price 8.0
Target Mean Price 10.0
Target Median Price 10.0
Total Cash 3,397,035
Total Cash Per Share 1.067
Total Debt 3,867,131
Total Revenue 8,669
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.31
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.67935
Two Hundred Day Average Change -0.039349794
Two Hundred Day Average Change Percent -0.014686322
Type Disp Equity
Volume 32,398
Website https://heartsciences.com
Zip 76,092